Moshe (Mori) Arkin

Moshe (Mori) Arkin is an Israeli billionaire businessman, investor, and the founder and chairman of Arkin Holdings, a pharmaceutical company and multi-asset manager.

Family Office Herzliya Pituah, Israel Est. 1952
Last updated 2026-09-01
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$8.3M
total disclosed, rounds participated
Stages
Seed, Series A, Series B, Late Stage, Growth, Public

About

Moshe "Mori" Arkin is a prominent Israeli billionaire businessman and investor. He founded Arkin Holdings in 2009, a multi-asset manager with over $2 billion under management across various investment arms including health, technology, equity, and real estate. Arkin's career began when he took over Agis Industries, a pharmaceutical company founded by his father, which he later sold to Perrigo in 2005 for $390 million. He is known for his strategic insights in healthcare investments, particularly in pharmaceuticals, biotechnology, and medical devices.

Portfolio · 1

Q&A

What is Moshe (Mori) Arkin's primary investment focus?
Moshe (Mori) Arkin, through Arkin Holdings, primarily focuses on empowering companies that create breakthrough pharma, biotech, and medical device technologies. The firm also invests in technology, equity, and real estate.
What is the total AUM for Arkin Holdings?
Arkin Holdings, founded by Moshe (Mori) Arkin, manages over $2 billion in assets.
What are the typical check sizes for Moshe (Mori) Arkin's investments?
Moshe (Mori) Arkin's typical check size for investments ranges from $3 million to $20 million.
Which investment stages does Moshe (Mori) Arkin target?
Moshe (Mori) Arkin invests across various stages including Seed, Series A, Series B, Late Stage, Growth, and Public.
What are the preferred sectors for Moshe (Mori) Arkin's investments?
Moshe (Mori) Arkin prefers sectors such as Health Tech & Life Sciences, Business Software, Industrial Technologies, Real Estate, Cyber Security, Fintech & Insurtech, and Automotive & Mobility Technologies.
Which geographies does Moshe (Mori) Arkin prioritize for investments?
Moshe (Mori) Arkin prioritizes investments in Israel, the US, and Europe.
When was Arkin Bio Ventures II raised and what was its size?
Arkin Bio Ventures II was raised in 2020 with a size of $140 million.
What is the most recent fund raised by Arkin Holdings?
Arkin Bio-Capital is the most recent fund, raised in 2021 with a size of $270 million.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)